Current biologics have to be given every two or four weeks, so a drug that can be given just twice a year would be a step up in patient convenience The SWIFT-1 and SWIFT-2 trials compared ...

In lab studies, the orally active drug has been shown to degrade the VAV1 protein expressed in T- and B- cells. VAV1 is thought to be a signalling protein involved in the production of pro ...

These judges ruled against Trump. Then their families came under attack. An intimidation campaign against federal judges who have ruled against the Trump administration has strained the judges and ...